SCLX Insider Trading

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	Bank of New York Mellon Corp	15,815	$31K	0.0%	N/A	0.009%
7/19/2024	Donald L. Hagan LLC	113,292	$0.22M	0.1%	+59.5%	0.063%
5/10/2024	Vanguard Group Inc.	3,988,265	$6.34M	0.0%	+1.4%	2.400%
4/17/2024	Cannon Global Investment Management LLC	25,000	$40K	0.1%	N/A	0.015%
4/9/2024	Collective Family Office LLC	21,950	$35K	0.0%	+68.4%	0.013%
2/13/2024	Tower Research Capital LLC TRC	20,595	$42K	0.0%	-82.7%	0.013%
2/12/2024	Focus Financial Network Inc. ADV	28,257	$58K	0.0%	N/A	0.018%
2/6/2024	Apollon Wealth Management LLC	36,100	$74K	0.0%	-27.8%	0.023%
1/19/2024	Donald L. Hagan LLC	52,343	$0.11M	0.1%	+49.1%	0.033%
12/7/2023	Hudson Bay Capital Management LP	474,683	$0.67M	0.0%	N/A	0.301%
10/24/2023	Bank of New York Mellon Corp	48,459	$68K	0.0%	N/A	0.032%
10/11/2023	Donald L. Hagan LLC	35,098	$49K	0.0%	+39.8%	0.023%
8/14/2023	Casdin Capital LLC	23,512	$0.13M	0.0%	N/A	0.016%
8/11/2023	Deuterium Capital Management LLC	23,994	$96K	0.1%	+25.8%	0.016%
8/10/2023	Ground Swell Capital LLC	12,085	$67K	0.2%	N/A	0.008%
8/7/2023	Wolverine Asset Management LLC	8,224	$46K	0.0%	N/A	0.006%
7/17/2023	Donald L. Hagan LLC	25,098	$0.14M	0.1%	+66.2%	0.017%
7/17/2023	GoalVest Advisory LLC	7,279	$41K	0.0%	N/A	0.005%
6/14/2023	State Board of Administration of Florida Retirement System	14,219	$0.12M	0.0%	N/A	0.010%
5/11/2023	Citigroup Inc.	239,130	$1.96M	0.0%	N/A	0.164%
5/11/2023	E Fund Management Co. Ltd.	31,431	$0.26M	0.0%	N/A	0.022%
5/9/2023	Tower Research Capital LLC TRC	10,538	$86K	0.0%	+1,159.0%	0.007%
5/9/2023	California State Teachers Retirement System	81,066	$0.67M	0.0%	N/A	0.056%
5/9/2023	US Bancorp DE	4,512	$37K	0.0%	N/A	0.003%
5/8/2023	New York Life Investment Management LLC	34,109	$0.28M	0.0%	N/A	0.023%
5/8/2023	Public Employees Retirement Association of Colorado	4,709	$39K	0.0%	N/A	0.003%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	8,554	$70K	0.0%	N/A	0.006%
5/5/2023	Mayo Clinic	42,303	$0.35M	0.3%	N/A	0.029%
5/2/2023	Amalgamated Bank	8,654	$71K	0.0%	N/A	0.006%
4/28/2023	Handelsbanken Fonder AB	11,168	$92K	0.0%	N/A	0.008%
4/27/2023	Arizona State Retirement System	17,904	$0.15M	0.0%	N/A	0.012%
4/18/2023	Donald L. Hagan LLC	15,098	$0.12M	0.1%	N/A	0.010%
4/18/2023	ETF Managers Group LLC	16,589	$0.14M	0.0%	N/A	0.011%
4/14/2023	Raymond James Financial Services Advisors Inc.	18,409	$0.15M	0.0%	N/A	0.013%
4/14/2023	Raymond James & Associates	31,303	$0.26M	0.0%	N/A	0.021%
4/11/2023	Asset Management Resources LLC	19,459	$0.16M	0.1%	N/A	0.013%

Data available starting January 2016

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California.

Today's Range

Now: $1.68

$1.62

$1.70

50 Day Range

MA: $1.57

$1.08

$2.15

52 Week Range

Now: $1.68

$0.73

$6.55

Volume

556,274 shs

Average Volume

1,089,719 shs

Market Capitalization

$305.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of Scilex?: Scilex's top insider investors include:
Jay Chun (Director)
Jaisim Shah (Insider)
Learn More about top insider investors at Scilex.
Who are the major institutional investors of Scilex?: Scilex's top institutional investors include:
Donald L. Hagan LLC — 0.06%
Bank of New York Mellon Corp — 0.01%
Learn More about top institutional investors of Scilex stock.
Which major investors are buying Scilex stock?: During the last quarter, SCLX stock was purchased by institutional investors including:
Donald L. Hagan LLC
Bank of New York Mellon Corp
During the previous year, these company insiders have bought Scilex stock:
Jay Chun (Director)
Jaisim Shah (Insider)
Learn More investors buying Scilex stock.